Milestone Pharmaceuticals Inc. (MIST) stock
MISTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.40−0.06 (-13.27%)
Close on Nov 19, 2026Market cap $49.71MP/E –Yield –
Milestone Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $527.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $224.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
See a number that looks wrong?